Compare SYK & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYK | BX |
|---|---|---|
| Founded | 1941 | 1985 |
| Country | United States | United States |
| Employees | N/A | 4895 |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2B | 116.4B |
| IPO Year | N/A | 2007 |
| Metric | SYK | BX |
|---|---|---|
| Price | $358.54 | $150.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $434.19 | $178.47 |
| AVG Volume (30 Days) | 1.6M | ★ 3.2M |
| Earning Date | 01-29-2026 | 01-29-2026 |
| Dividend Yield | 0.99% | ★ 2.63% |
| EPS Growth | N/A | ★ 19.48 |
| EPS | ★ 7.61 | 3.48 |
| Revenue | ★ $24,381,000,000.00 | $12,791,218,000.00 |
| Revenue This Year | $12.01 | $4.47 |
| Revenue Next Year | $8.61 | $24.33 |
| P/E Ratio | $46.65 | ★ $43.25 |
| Revenue Growth | 10.95 | ★ 14.84 |
| 52 Week Low | $329.16 | $115.66 |
| 52 Week High | $406.19 | $190.09 |
| Indicator | SYK | BX |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 42.70 |
| Support Level | $350.83 | $153.81 |
| Resistance Level | $365.30 | $165.14 |
| Average True Range (ATR) | 7.55 | 4.90 |
| MACD | -0.32 | -1.12 |
| Stochastic Oscillator | 36.54 | 15.15 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).